Jaguar Health, Inc.

Equities

JAGX

US47010C8881

Market Closed - Nasdaq Other stock markets 02:30:00 17/01/2026 am IST			After hours 06:29:58 am
1.430 ^USD	+87.05%		1.065	-25.52%

16/01	Jaguar Health Inc - Co & unit entered license agreement with Woodward Specialty LLC - SEC filing	RE
06/01	Jaguar Health, Inc. announced that it has received $0.35 million in funding	CI

Transcript : Jaguar Health, Inc., Q3 2025 Earnings Call, Nov 17, 2025

Published on 11/17/2025 at 07:50 pm IST - Modified on 11/29/2025 at 02:53 am IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Greetings, and welcome to the Jaguar Health's Investor Webcast. [Operator Instructions] As a reminder, this conference is being recorded.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

Latest news about Jaguar Health, Inc.

16/01	Jaguar Health Inc - Co & unit entered license agreement with Woodward Specialty LLC - SEC filing	RE
06/01	Jaguar Health, Inc. announced that it has received $0.35 million in funding	CI
24/11	Jaguar Health, Inc. announced that it has received $10.81 million in funding	CI
21/11	Sector Update: Health Care Stocks Softer Late Afternoon	MT
21/11	Sector Update: Health Care	MT
21/11	Jaguar Health's Napo Pharmaceuticals Submits Amended Crofelemer Trial Protocol to FDA	MT
17/11	Jaguar Health, Inc., Q3 2025 Earnings Call, Nov 17, 2025
17/11	Gastrointestinal drugmaker Jaguar Health's Q3 net loss narrows	RE
15/11	Jaguar Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
12/11	Jaguar Health, Inc. announced that it expects to receive $10.81 million in funding	CI
10/25/10	Jaguar Health, Inc. announced that it has received $0.999951 million in funding from Brown Stone Capital, LTD	CI
04/25/04	Jaguar Health files for resale of up to 2.6 million shares by selling stockholders - SEC filing	RE
02/25/02	Jaguar Health says on September 28 entered securities purchase agreement with Brown Stone Capital Limited - SEC filing	RE
28/25/28	Jaguar Health, Inc. announced that it expects to receive $0.999951 million in funding from Brown Stone Capital, LTD	CI
24/25/24	Jaguar Health Unit Submits Orphan Drug Status Application to US FDA for Cancer Therapy-Related Diarrhea Drug	MT
10/25/10	Jaguar Health, Inc. announced that it has received $2.380001 million in funding	CI
09/25/09	Jaguar Health, Inc. announced that it expects to receive $2.380001 million in funding	CI
15/25/15	Jaguar Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
14/25/14	Jaguar Health enters sixth ATM amendment with Ladenburg and Lucid	RE
14/25/14	Jaguar Health, Inc., Q2 2025 Earnings Call, Aug 14, 2025
25/25/25	Jaguar Health to Seek European Regulatory Approval for Dog Diarrhea Treatment	MT
11/25/11	Jaguar Health Establishes First Site for Canalevia-CA1 Field Study	MT
21/25/21	Jaguar Health Prices Offering of Shares, Warrants	MT
16/25/16	Jaguar Health, Inc., Q1 2025 Earnings Call, May 15, 2025
15/25/15	Jaguar Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI